Lista de obras -

20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis

scientific article published on 23 January 2008

A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia

artículo científico publicado en 2009

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

scientific article published on 13 December 2019

Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia

artículo científico publicado en 2010

Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemia

artículo científico publicado en 2016

Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes

artículo científico publicado en 2020

Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL).

artículo científico publicado en 2016

Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis

artículo científico publicado en 2009

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre

artículo científico publicado en 2018

B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome

artículo científico publicado en 2008

Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression

artículo científico publicado en 2009

Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia

artículo científico publicado en 2009

CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.

artículo científico publicado en 2010

Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes

artículo científico publicado en 2013

Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center

scientific article published on 13 June 2019

Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia

artículo científico publicado en 2008

Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia

artículo científico publicado en 2005

Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia

artículo científico publicado en 2006

Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance

artículo científico publicado en 2009

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

artículo científico publicado en 2010

Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients

artículo científico publicado en 2013

Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia

artículo científico publicado en 2020

Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors

scientific article published on 01 February 2006

Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia

artículo científico publicado en 2006

Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

artículo científico publicado en 2011

Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.

artículo científico publicado en 2015

Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes

artículo científico publicado en 2015

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

artículo científico publicado en 2019

Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice

scientific article published on 25 May 2020

Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls

artículo científico publicado en 2012

Infectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare, but important, complication

artículo científico publicado en 2014

JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance

artículo científico

JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patients

artículo científico publicado en 2008

Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera

artículo científico publicado en 2009

Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

artículo científico publicado en 2017

Mature survival data for 176 patients younger than 60 years with primary myelofibrosis diagnosed between 1976 and 2005: evidence for survival gains in recent years

artículo científico publicado en 2009

Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features

artículo científico publicado en 2007

Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis

artículo científico publicado en 2007

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis

artículo científico publicado en 2018

Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic

artículo científico publicado en 2006

Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice

artículo científico publicado en 2016

Phase1/-2 study of Pomalidomide in myelofibrosis

artículo científico publicado en 2010

Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch

artículo científico publicado en 2010

Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies

artículo científico publicado en 2009

Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis

artículo científico publicado en 2006

Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system

artículo científico publicado en 2006

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice

artículo científico publicado en 2019

Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not.

artículo científico publicado en 2009

Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience

artículo científico publicado en 2015

Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia

artículo científico publicado en 2007

Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis

artículo científico publicado en 2015

Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL)

artículo científico publicado en 2020

Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia

artículo científico publicado en 2013

Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia

artículo científico publicado en 2010

Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population

scientific article published on 12 August 2011

The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

artículo científico publicado en 2005

The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis

artículo científico publicado en 2009

The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera

artículo científico

The efficacy of ibrutinib in the treatment of Richter syndrome

artículo científico publicado en 2015

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice

scientific article published on 18 March 2020

The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma

artículo científico publicado en 2008

The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor

scientific article published on 23 January 2020

Thrombosis in myelofibrosis: prior thrombosis is the only predictive factor and most venous events are provoked ⬇️

artículo científico publicado el 1 de octubre de 2010

Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype

artículo científico publicado en 2010

Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone

artículo científico publicado en 2010

Trisomy 13: prevalence and clinicopathologic correlates of another potentially lenalidomide-sensitive cytogenetic abnormality

artículo científico publicado en 2009

Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

artículo científico publicado en 2014

Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution

artículo científico publicado en 2007

Validation of a new prognostic index for patients with chronic lymphocytic leukemia

scientific article published on January 2009

Lista de obras de

20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis

A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia

Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemia

Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes

Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL).

Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre

B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome

Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression

Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia

CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.

Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes

Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center

Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia

Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia

Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia

Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients

Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia

Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors

Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia

Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.

Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice

Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls

Infectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare, but important, complication

JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance

JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patients

Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera

Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

Mature survival data for 176 patients younger than 60 years with primary myelofibrosis diagnosed between 1976 and 2005: evidence for survival gains in recent years

Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features

Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis

Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic

Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice

Phase1/-2 study of Pomalidomide in myelofibrosis

Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch

Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies

Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis

Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice

Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not.

Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience

Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia

Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis

Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL)

Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia

Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia

Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population

The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis

The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera

The efficacy of ibrutinib in the treatment of Richter syndrome

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice

The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma

The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor

Thrombosis in myelofibrosis: prior thrombosis is the only predictive factor and most venous events are provoked ⬇️

Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype

Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone

Trisomy 13: prevalence and clinicopathologic correlates of another potentially lenalidomide-sensitive cytogenetic abnormality

Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution

Validation of a new prognostic index for patients with chronic lymphocytic leukemia